Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer
NCT01322152
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
irinotecan, capecitabine
Sponsor
Fudan University